CA18386 - Nova Education Trust Tender for the Provision of Inclusion Centres and Behaviour Services

NHS Essex Integrated Care Board is undertaking a Competitive Process under the Health Care Services (Provider Selection Regime) Regulations 2023 for the award of a General Medical Services (GMS) contract for Tollgate Practice, Stanway, Colchester. The Authority seeks a suitably qualified provider to deliver primary medical services to a registered patient population of approximately 10,206 patients. Services will be provided under a nationally prescribed GMS contract from the existing practice premises and will include the delivery of core primary medical services, management of the registered patient list, clinical governance, safeguarding, information governance and integration with local health and care services. This procurement is being undertaken to secure the long-term provision of stable, resilient and high-quality primary medical services for the local population. Due to the fixed practice location, established patient list and requirement for uninterrupted service delivery, bidders must demonstrate the ability to mobilise and maintain an appropriately qualified workforce and robust governance arrangements from contract commencement. The contract will be awarded following evaluation against the key criteria set out in the Health Care Services (Provider Selection Regime) Regulations 2023. The estimated contract value is £21,896,491.60, calculated using a notional 20-year term for valuation purposes only. The contract itself is a perpetual GMS contract and is not time limited. Additional information: To express interest and participate in the tender, please register and apply via Atamis e-sourcing portal https://health-family.force.com/s/Welcome. Should Tenderers have any queries, or having problems using the portal, they should contact Helpdesk at: Phone: 0800 9956035 E-mail: support-health@atamis.co.uk

Please see tender documentation.

Delivering interventions to children with speech, language, communication, or swallowing and eating needs to help them reach their full communication potential. This includes delivering direct interventions in line with a Child's Education, Health, and Care Plan (EHCP), as well as offering indirect support through professional training and parent/carer guidance. This provision will work across Young Hackney, Youth Justice Virtual School, Schools, and Early Years provision. This contract will include for the provision of Speech and Language Therapists as part of the Hackney Experts at Hand team, in line with requirements related to the Department for Education's Experts at Hand initiative. This initiative is seeking to improve the capability of mainstream education settings to meet the needs of children and young people with SEND more effectively, by providing a new route to access expert advice and support from health professionals. The contract start date is expected to be 1st April 2027 with an initial term of 3 years, and two extension options each of a year; for a total possible contract length of 5 years.

East Suffolk and North Essex NHS Foundation Trust (ESNEFT) is inviting qualified providers to express an interest to participate in a tender exercise for; Managed Service for the Provision of Renal Dialysis Services under the Provider Selection Regime To access this competition: Registered: Login to https://suppliers.multiquote.com and view the opportunity CA18304. Not registered: Visit https://suppliers.multiquote.com then register and quote CA18304 as the reason for registration. Any queries please contact MultiQuote on 020 3920 8054.

Delivering interventions that support children take part in everyday activities; ensuring they can care for themselves, undertake productive occupations (e.g., writing, learning), play, and have fun. The service will also equip parents/carers, and professionals with the tools and knowledge to support children with illnesses or Special Educational Needs and Disabilities (SEND). This provision will work across Hackney's Virtual School and Disabled Children's Service. This contract will include the provision of Occupational Therapists as part of the Hackney Experts at Hand team, in line with requirements related to the Department for Education's Experts at Hand initiative. This initiative is seeking to improve the capability of mainstream education settings to meet the needs of children and young people with SEND more effectively, by providing a new route to access expert advice and support from health professionals. The contract start date is expected to be 1st April 2027 with an initial term of 3 years, and two extension options each of a year; for a total possible contract length of 5 years.

The Trust is looking to appoint a supplier to provide CAMHs Tier 4 bed and associated services in the BNSSG area. To access this competition: Registered: Login to https://suppliers.multiquote.com and view the opportunity CA18336. Not registered: Visit https://suppliers.multiquote.com then register and quote CA18336 as the reason for registration. Any queries please contact MultiQuote on 020 3920 8054.

Nova Education Trust is seeking to appoint a single strategic partner to provide a fully integrated IT Security and internet filtering platform across the Trust. The Trust operates a diverse educational environment comprising primary, secondary and post-16 settings, supporting approximately 12,000 students, 5,000 endpoint devices, over 140 servers and 19 school sites. The current security environment includes firewall infrastructure, internet filtering, endpoint and server protection, and managed threat detection and response services. To access this competition: Registered: Login to https://suppliers.multiquote.com and view the opportunity CA18385. Not registered: Visit https://suppliers.multiquote.com then register and quote CA18385 as the reason for registration. Any queries please contact MultiQuote on 020 3920 8054.

Expected Impact: The action under this topic is expected to achieve the following impacts and contribute to the following EU policies/initiatives: deliver innovative, early technology solutions that contribute to addressing strategic unmet public health needs across multiple therapy areas to improve prevention, early diagnosis, and treatment; leverage the unique network and scale of IHI JU members to create a pipeline to support innovative startups in the health industry, fully integrated into European initiatives in support of start-ups and entrepreneurship; drive early cross-sector health R&D and innovation to strengthen the European healthcare industry’s global competitiveness, contributing to the EU Industrial Strategy and Pharmaceutical Strategy objectives; create a sustainable network of European healthcare incubators to guide and support highly talented and innovative early-stage companies; harness digital health and data-sharing technologies (e.g., AI and big data) to enable interoperable health solutions, contributing to the European Health Data Space (EHDS) and improved evidence based care;- the action should generate a portfolio of early‑stage companies that have…

Expected Impact: The action under this topic is expected to achieve the following impacts: Faster and more informed decision-making through the use of an AI-driven NAM (AI Foundation Toxicology Model) and increased efficiency through rapid processing of vast amounts of data [1] . Increased consistency and standardisation in a NAM-based approach, specifically an AI model, used by industry in the efficient development, testing and production of safe and effective innovative health technologies, improving industrial competitiveness. Regulatory adoption of a NAM-enabled second species waiver model (AI Foundation Toxicology Model) and weight-of-evidence framework, in line with recommendations and more consistent global decision-making on waiving second species testing. Reduction in animal use, accelerated timelines and lower costs, enhancing the competitiveness of the European health industry through economical and ethical benefits. Improved public health as patients will benefit from safe and effective medicines developed faster using validated NAMs. The action is expected to contribute to the EU Directive (2010/63/EU) [2] on the protection of animals used for scientific purposes and…

Expected Impact: The action under this topic is expected to achieve the following impacts: Accelerate EU access to more cost-effective interventions in an increasingly ageing population by identifying personalised treatment approaches for elderly-onset immune diseases. Decrease disease risk later in life by defining specific prevention strategies based on ageing biomarkers and risk factors. Halt age-associated disease exacerbation by the identification of predictive and digital biomarkers that can stratify patients for early intervention. Improve quality of life for healthy individuals and patients by preventing further health decline, avoiding escalating care costs, and properly stratifying individuals earlier in the diagnostic pathway. Accelerate adoption of innovative diagnostic, preventative, and therapeutic strategies, strengthening the EU’s position as a healthcare innovator. Evaluate digital biomarker as potential regulatory endpoints in the ultimate goal to develop medicines for ‘healthy ageing’. Integrate fragmented research efforts by bringing together health industry sectors and stakeholders to develop clinical and multi-omics data integration capabilities. Enable new…